GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmesis International Ltd (SGX:BFK) » Definitions » 5-Year Yield-on-Cost %

Pharmesis International (SGX:BFK) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 27, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Pharmesis International 5-Year Yield-on-Cost %?

Pharmesis International's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Pharmesis International's 5-Year Yield-on-Cost % or its related term are showing as below:



SGX:BFK's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.3
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Pharmesis International's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmesis International's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmesis International's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmesis International's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Pharmesis International's 5-Year Yield-on-Cost % falls into.


;
;

Pharmesis International 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Pharmesis International is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Pharmesis International  (SGX:BFK) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Pharmesis International 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Pharmesis International's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmesis International Business Description

Traded in Other Exchanges
N/A
Address
5 Kallang Sector, No. 03-02, Singapore, SGP, 349279
Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its operating segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM-formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution. The company derives revenue from the sale of medicines to domestic customers in China.